Combatting disease with antibody drug conjugates
Tune into this episode where we investigate how antibody drug conjugates can be optimised, as well as the future of the field.
List view / Grid view
Tune into this episode where we investigate how antibody drug conjugates can be optimised, as well as the future of the field.
Tune in to this episode where we explore how innovative assays and human-relevant cell models are transforming toxicity screening in drug development.
In this episode, we explore how mRNA technology could revolutionise cancer therapeutics.
In this episode, we discuss how new insights into stem cell biology are leading to novel therapeutics in regenerative medicine beyond cell therapy.
In this episode, we explore our understanding of DNA and its implications for health outcomes. Additionally, we discuss the transition from DNA sequencing to actionable insights in medicine, contrasting genetics-driven drug discovery with traditional methods. Finally, we examine the evolving landscape of genetic technology and its potential impact on the…
In this episode, we discuss the current advantages and limitations of using organoids, as well as where the field is heading.
In this episode, we explore the current status and potential solutions to addressing major hurdles in oncology.
Tune in to this episode where we discuss the opportunities CRISPR/Cas technology offers to revolutionise drug discovery.
Listen to this podcast where we explore the latest technological advancements in high throughput screening and more.
Listen to this podcast where we step into the new year and explore research insights and projections for the field in 2024 in neuroscience.
Listen to this podcast where we dive into genetic engineering, its role and relationship with allogeneic immunotherapy.
Tune into this podcast to understand why researchers are turning to 3D Organoids and how organoids can be made ready for screening.
Tune into this podcast to hear experts discussing the tumour microenvironment in immuno-oncology!
This episode defines allogeneic cell therapy as the administration of cells to a patient for therapeutic use, that were not initially taken from that patient.
Tune in to this episode to hear experts discussing the hot topic that is AI and how AI technology is used in drug discovery, looking specifically at how Biotechs & Pharma are trying to keep up with emerging technology.